- Laboratory >
- Laboratory medicine >
- Tumor marker reagent >
- Fujirebio
Fujirebio tumor marker reagents
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
... now widely used for detection and management of patients with prostatic cancer and considered as the superior serological marker for cancer of the prostate3. PSA has been shown to form stable complexes with different ...
Fujirebio
... determination of AFP in serum may be valuable in the management of patients with suspected or diagnosed liver cancer or germ cell tumors of the testis or ovary
Fujirebio
CA125 is a high molecular weight mucin-type glycoprotein, originally defined by the Oc125 monoclonal antibody (MAb) established by Bast et al.1. Different epitopes, co-expressed with the Oc125 epitope on the CA125 antigen, have been used ...
Fujirebio
... PDTRPAPG region of the protein core2-5.The MUC 1 breast cancer mucin (CA15-3 antigen) is secreted from tumor cells and is a well-established serological marker for monitoring the clinical course of breast ...
Fujirebio
The CanAg CA19-9 EIA is based on a mouse monoclonal antibody, C192, highly specific for the sialyl Lewisa epitope, also known as CA19-9 antigen1. In adults, the epitope is typically expressed in trace amounts on mucosal cells of gastrointestinal ...
Fujirebio
The tumor marker CA242™ is defined by the monoclonal antibody C242™. The chemical structure of the antigenic determinant is not exactly known, but the determinant has been shown to be a sialylated carbohydrate ...
Fujirebio
... on two mouse monoclonal antibodies against the Gold epitopes IV and V3, 4. CEA is secreted from tumor cells and is a widely used serological marker of gastrointestinal carcinomas, lung cancer, and ...
Fujirebio
... now widely used for detection and management of patients with prostatic cancer and considered as the superior serological marker for cancer of the prostate3. PSA has been shown to form stable complexes with different ...
Fujirebio
The HE4 EIA is an enzyme immunometric assay for the quantitative determination of HE4 in human serum. The assay is to be used as an aid in monitoring response to therapy for patients with invasive epithelial ovarian cancer. The HE4 ...
Fujirebio
use as an assayed quality control serum to monitor the accuracy of laboratory testing for neuron specific enolase (NSE), S100B protein and squamous cell carcinoma antigen (SCCA). The use of a quality control serum is indicated to verify ...
Fujirebio
Your suggestions for improvement:
Receive monthly updates on this section.
Please refer to our Privacy Policy for details on how MedicalExpo processes your personal data.
- Brand list
- Manufacturer account
- Buyer account
- Our services
- Newsletter subscription
- About VirtualExpo Group
Please specify:
Help us improve:
remaining